Report Detail

Pharma & Healthcare Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status and Forecast 2021-2027

  • RnM4335202
  • |
  • 20 July, 2021
  • |
  • Global
  • |
  • 166 Pages
  • |
  • GRD Survey
  • |
  • Pharma & Healthcare

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status and Forecast (2016-2027)
      • 1.3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Supply by Company

    • 2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume by Company
    • 2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Value by Company
    • 2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Company
    • 2.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status by Type

    • 3.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type Introduction
      • 3.1.1 Control Hyperphosphatemia
      • 3.1.2 Maintain Blood Calcium Levels
      • 3.1.3 Control PTH Level
      • 3.1.4 Correct Acidosis
      • 3.1.5 Other
    • 3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market by Type
      • 3.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume by Type (2016-2021)
      • 3.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Value by Type (2016-2021)
      • 3.2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Type (2016-2021)
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status by Application

    • 4.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Segment by Application
      • 4.1.1 Hospital Pharmacies
      • 4.1.2 Retail Pharmacies
      • 4.1.3 Online Pharmacies
      • 4.1.4 Drug Stores
      • 4.1.5 Other
    • 4.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market by Application
      • 4.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume by Application (2016-2021)
      • 4.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Value by Application (2016-2021)
      • 4.2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Application (2016-2021)
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status by Region

    • 5.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market by Region
      • 5.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume by Region
      • 5.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Value by Region
    • 5.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status
    • 5.3 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status
    • 5.4 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status
    • 5.5 Central & South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status
    • 5.6 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status

    6 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status

    • 6.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market by Country
      • 6.1.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume by Country (2016-2021)
      • 6.1.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status

    • 7.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market by Country
      • 7.1.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status

    • 8.1 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market by Country
      • 8.1.1 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status

    • 9.1 Central & South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market by Country
      • 9.1.1 Central & South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status

    • 10.1 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market by Country
      • 10.1.1 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Cost Analysis
    • 11.5 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Channel and Distributors Analysis
      • 11.5.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Channel
      • 11.5.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Distributors
    • 11.6 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Downstream Major Buyers

    12 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Forecast by Type and by Application

    • 12.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Forecast by Type
      • 12.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume Forecast by Type
      • 12.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Value Forecast by Type
      • 12.2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price Forecast by Type
    • 12.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Forecast by Application
      • 12.3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume Forecast by Application
      • 12.3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Value Forecast by Application
      • 12.3.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price Forecast by Application

    13 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Forecast by Region/Country

    • 13.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Forecast by Region (2022-2027)
      • 13.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Vifor
      • 14.1.1 Company Information
      • 14.1.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Introduction
      • 14.1.3 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Takeda
      • 14.2.1 Company Information
      • 14.2.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Introduction
      • 14.2.3 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Spectrum
      • 14.3.1 Company Information
      • 14.3.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Introduction
      • 14.3.3 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Shield
      • 14.4.1 Company Information
      • 14.4.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Introduction
      • 14.4.3 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Sanofi Genzyme
      • 14.5.1 Company Information
      • 14.5.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Introduction
      • 14.5.3 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 OPKO
      • 14.6.1 Company Information
      • 14.6.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Introduction
      • 14.6.3 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Novadiol
      • 14.7.1 Company Information
      • 14.7.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Introduction
      • 14.7.3 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Japan Tobacco Company
      • 14.8.1 Company Information
      • 14.8.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Introduction
      • 14.8.3 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Fresenius
      • 14.9.1 Company Information
      • 14.9.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Introduction
      • 14.9.3 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Daiichi-Sankyo
      • 14.10.1 Company Information
      • 14.10.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Introduction
      • 14.10.3 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 SWOT Analysis
    • 14.11 Astellas
    • 14.12 Ardelyx
    • 14.13 Amgen
    • 14.14 Akebia
    • 14.15 Abbvie
    • 14.16 Abbott

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to this survey, the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      Control Hyperphosphatemia
      Maintain Blood Calcium Levels

      Segmented by Application
      Hospital Pharmacies
      Retail Pharmacies
      Online Pharmacies
      Drug Stores 
      Other

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Spectrum
      Shield
      Sanofi Genzyme
      OPKO
      Novadiol
      Japan Tobacco Company
      Fresenius
      Daiichi-Sankyo
      Astellas
      Ardelyx
      Amgen
      Akebia
      Abbvie
      Abbott


      Summary:
      Get latest Market Research Reports on Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD). Industry analysis & Market Report on Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) is a syndicated market report, published as Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status and Forecast 2021-2027. It is complete Research Study and Industry Analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,980.00
      $4,470.00
      $5,960.00
      2,151.56
      3,227.34
      4,303.12
      2,521.08
      3,781.62
      5,042.16
      327,680.80
      491,521.20
      655,361.60
      221,861.00
      332,791.50
      443,722.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report